Treatment of CKD-associated Pruritus—a new FDA approved treatment - Docwire News
Doc Wire News,
The approval by the US FDA on August 23, 2021, of difelikefalin (marketed as Korsuva™ by Cara Therapeutics) is a major step in…
An evaluation of difelikefalin as a treatment option for moderate-to-severe pruritus in end stage renal disease
Overview of attention for article published in Expert Opinion on Pharmacotherapy, December 2020
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (83rd percentile)
-
High Attention Score compared to outputs of the same age and source (94th percentile)
Readers on
- mendeley
- 32 Mendeley